Yahoo Finance • 2 months ago
We recently compiled a list of the Top 10 Holdings of Caligan Partners.In this article, we are going to take a look at where Outlook Therapeutics Inc (NASDAQ:OTLK) stands against Caligan Partners' other top holdings. Founded in 2017, Cali... Full story
Yahoo Finance • 10 months ago
LOS ANGELES, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the d... Full story
Yahoo Finance • 10 months ago
NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Outlook Therapeutics, Inc. ("Outlook" or the "Company") (NASDAQ: OTLK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to... Full story
Yahoo Finance • 10 months ago
NEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outlook Therapeutics, Inc. (NASDAQ: OTLK) between December 29, 2022 and August 29, 2023, both dates... Full story
Yahoo Finance • 10 months ago
BENSALEM, Pa., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the d... Full story
Yahoo Finance • 10 months ago
NEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Outlook Therapeutics, Inc. (NASDAQ: OTLK)?Did you purchase your shares between December 29, 2022 and August 29, 2023, inclusive? Did... Full story
Yahoo Finance • 10 months ago
LOS ANGELES, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming January 2, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased... Full story
Yahoo Finance • 10 months ago
Resubmission of the ONS-5010 BLA on track for the end of calendar year 2024, pending final agreement on a clinical trial protocol with the FDA and successful completion of the required additional clinical trialPlanned clinical trial expect... Full story
Yahoo Finance • 10 months ago
SAN DIEGO, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & DowdLLP announces that purchasers or acquirers of Outlook Therapeutics, Inc. (NASDAQ: OTLK) securities between December 29, 2022 and August 29, 2023, in... Full story
Yahoo Finance • 10 months ago
NEW YORK, Nov. 26, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Outlook Therapeutics, Inc. (“Outlook” or t... Full story
Yahoo Finance • 10 months ago
If you purchased or acquired securities in Outlook between December 29, 2022 and August 29, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Yo... Full story
Yahoo Finance • 10 months ago
NEW YORK, Nov. 25, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outlook Therapeutics, Inc. (NASDAQ: OTLK) between December 29, 2022 and August 29, 2023, both dates... Full story
Yahoo Finance • 10 months ago
SAN DIEGO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action lawsuit on behalf of persons and entities that purchased or otherwise acquired Outlook Therapeutics, Inc. (NASDAQ: OTLK) s... Full story
Yahoo Finance • 10 months ago
NEW YORK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Outlook Therapeutics, Inc. (“Outlook” or the “Company”) (NASDAQ: OTLK) and certain officers. The class action, filed i... Full story
Yahoo Finance • 10 months ago
NEW YORK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Attention Outlook Therapeutics, Inc. ("Outlook") (NASDAQ: OTLK) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purc... Full story
Yahoo Finance • 10 months ago
NEW YORK, Nov. 16, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Outlook Therapeutics, Inc. (NASDAQ: OTLK) between December 29, 2022 and August 29, 2023, both dates... Full story
Yahoo Finance • 10 months ago
NEW YORK, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired Outlook Therapeutics, Inc. (“Outlook” or the “Company”)... Full story
Yahoo Finance • 10 months ago
NEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Outlook Therapeutics, Inc. ("Outlook" or the "Company") (NASDAQ: OTLK) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to... Full story
Yahoo Finance • 10 months ago
If you purchased or acquired securities in Outlook between December 29, 2022 and August 29, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Yo... Full story
Yahoo Finance • 10 months ago
ISELIN, N.J., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to achieve FDA approval for the first ophthalmic formulation of bevacizumab for the treatment of retinal disea... Full story